Your browser doesn't support javascript.
loading
Tenofovir Alafenamide for HIV Prevention: Review of the Proceedings from the Gates Foundation Long-Acting TAF Product Development Meeting.
Romano, Joseph W; Baum, Marc M; Demkovich, Zach R; Diana, Frank; Dobard, Charles; Feldman, Paul L; Garcia-Lerma, J Gerardo; Grattoni, Alessandro; Gunawardana, Manjula; Ho, Duy-Khiet; Hope, Thomas J; Massud, Ivana; Milad, Mark; Moss, John A; Pons-Faudoa, Fernanda P; Roller, Shane; van der Straten, Ariane; Srinivasan, Selvi; Veazey, Ronald S; Zane, Doris.
  • Romano JW; NWJ Group, LLC., Wayne, Pennsylvania, USA.
  • Baum MM; Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA.
  • Demkovich ZR; RTI International, Durham, North Carolina, USA.
  • Diana F; FJD-CMC Consulting, LLC., Ocean City, New Jersey, USA.
  • Dobard C; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Feldman PL; Intarcia Therapeutics, Inc., Research Triangle Park, North Carolina, USA.
  • Garcia-Lerma JG; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Grattoni A; Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas, USA.
  • Gunawardana M; Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA.
  • Ho DK; Department of Bioengineering, University of Washington, Seattle, Washington, USA.
  • Hope TJ; Department of Cell and Developmental Biology, Northwestern University, Chicago, Illinois, USA.
  • Massud I; Division of HIV/AIDS Prevention, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Milad M; Milad Pharmaceutical Consulting, Plymouth, Michigan, USA.
  • Moss JA; Department of Chemistry, Oak Crest Institute of Science, Monrovia, California, USA.
  • Pons-Faudoa FP; Department of Nanomedicine, Houston Methodist Research Institute, Houston, Texas, USA.
  • Roller S; Intarcia Therapeutics, Inc., Research Triangle Park, North Carolina, USA.
  • van der Straten A; Women's Global Health Imperative, RTI International, Berkeley, California, USA.
  • Srinivasan S; Department of Medicine, Center for AIDS Prevention Study (CAPS), UCSF, San Francisco, California, USA.
  • Veazey RS; Department of Bioengineering, University of Washington, Seattle, Washington, USA.
  • Zane D; Department of Pathology and Laboratory Medicine, Tulane University School of Medicine, New Orleans, Louisiana, USA.
AIDS Res Hum Retroviruses ; 37(6): 409-420, 2021 06.
Article en En | MEDLINE | ID: mdl-33913760
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH / Profilaxis Pre-Exposición Límite: Adolescent / Animals / Female / Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Infecciones por VIH / Fármacos Anti-VIH / Profilaxis Pre-Exposición Límite: Adolescent / Animals / Female / Humans Idioma: En Año: 2021 Tipo del documento: Article